RAPID KOR, NCT01913535: Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression |
|
|
| Terminated | 2 | 8 | US | CERC-501, Placebo | Massachusetts General Hospital, National Institute of Mental Health (NIMH), Butler Hospital, Rush University, Temple University, University of Kansas | Treatment Resistant Depression | 01/16 | 01/16 | | |
